Caplin Point Laboratories
₹1,536
38
+₹30.5+2.03% Friday 09:59
Statistics
Day High
1,558.1
Day Low
1,505.5
52W High
1,619.05
52W Low
850
Volume
57,530
Avg. Volume
141,520
Mkt Cap
114.92B
P/E Ratio
25.19
Dividend Yield
0.33%
Dividend
5
Upcoming
14
SEP
Dividend Ex
6
OCT
Dividend Payment
31
MAY 25
Dividend Ex
11
JUN 25
Dividend Payment
14
SEP 25
Dividend Ex
6
OCT 25
Dividend Payment
31
MAY 26
Dividend Ex
11
JUN 26
Dividend Payment
14
SEP 26
Dividend Ex
6
OCT 26
Dividend Payment
Dividends
0.33%Dividend Yield
10Y Growth
2.26%
5Y Growth
17.84%
3Y Growth
18.56%
1Y Growth
11.11%
Earnings
22MayConfirmed
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CAPLIPOINT.NSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. It provides liquid and lyophilized vials, pre-filled syringes, 3-pc ophthalmic droppers, pre-mix bags, dry and liquid syrups-bottles, tables, soft gels, capsules, suppositories, liquid and emulsion injectables in ampoules and vials, topicals, and sachets. The company was incorporated in 1990 and is headquartered in Chennai, India.
Show more...
CEO
Dr. Sridhar Ganesan
Country
IN
ISIN
INE475E01026